RecruitingNot ApplicableNCT05302375

Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2)

Sponsor

Dartmouth-Hitchcock Medical Center

Enrollment

30 participants

Start Date

Jul 1, 2024

Study Type

INTERVENTIONAL

Conditions

Cancer Depression

Summary

The purpose of this study is to determine the extent to which an online pathway to depression treatment (iPath\*D) is acceptable and usable to patients receiving cancer treatment who report symptoms of depression.

Eligibility

Min Age: 18 Years

Inclusion Criteria4

Adults (≥18 years)
New patients who are beginning treatment at Dartmouth Cancer Center North and returning for their chemo teach or radiation simulation visit
Can communicate in English
PHQ-9 ≥10 and ≤27

Exclusion Criteria5

Mild Depression (PHQ-9 ≥10)
Individuals who screen positive for suicidal ideation with method, intent, plan or a recent prior suicide/self-harm attempt, as determined by a positive endorsement of items 3, 4, 5 or 6 on the Columbia-Suicide Severity Rating Scale (C-SSR).
Individuals with bipolar disorder or psychosis (documented in the EMR)
Individuals currently receiving treatment for a mental health condition (documented in the EMR or self-reported during eligibility screening)
Significant cognitive impairment (Callahan's Six Item Screener of cognitive function ≤ 4; Self-reported during eligibility screening)